Diabetic Macular Edema
📧 Sign up to get email alerts when something new happens for Diabetic Macular Edema.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-12-19Clinical Trial Update: Performance Assessment Tests in Working Individuals With DME Following Treatment With Ranibizumab [Phase 4]
Phase 4 trial assessing performance assessment tests in working individuals with diabetic macular edema treated with ranibizumab; study comp…
-
CLINICAL_TRIALS trial_result · 2018-12-07Clinical Trial Update: Phase 2 Randomized Clinical Trial of Luminate® as Compared to Avastin® in the Treatment of Diabetic Macular Edema [Phase 2]
A Phase 2 randomized trial comparing Luminate to Avastin for diabetic macular edema has completed recruitment with results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-11-30Clinical Trial Update: Laser (Selective Retina Therapy) and Drug Combined Intervention in Clinically Significant Diabetic Macular Edema [Phase 4]
Phase 4 clinical trial evaluating a laser selective retina therapy combined with a drug for diabetic macular edema; status is unknown.
-
CLINICAL_TRIALS trial_result · 2018-11-14Clinical Trial Update: Non-damaging Retinal Laser Therapy With PASCAL Laser for Macular Diseases [Phase 2]
Phase 2 clinical trial exploring non-damaging retinal laser therapy (PASCAL) for macular diseases; status and results not provided.
-
CLINICAL_TRIALS trial_result · 2018-11-13Clinical Trial Update: Trial of Switching Between Intravitreal Bevacizumab (Avastin®)& Intravitreal Dexamethasone (Ozurdex™) for Persistent Diabetic Macular Oedema [Phase 2]
Phase 2 trial comparing switching between intravitreal bevacizumab and intravitreal dexamethasone for persistent diabetic macular edema have…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-10-03Clinical Trial Update: Anti-vasculaR Endothelial Growth Factor plUs Anti-angiopoietin 2 in Fixed comBination therapY: Evaluation for the Treatment of Diabetic Macular Edema [Phase 2]
Phase 2 trial evaluating a combination of anti-VEGF and anti-angiopoietin-2 for diabetic macular edema has completed with results posted in …
-
CLINICAL_TRIALS trial_result · 2018-09-27Clinical Trial Update: Empagliflozin Reduces Progression of Diabetic Retinopathy in Patients With High Risk of Diabetic Macular Edema [Phase 4]
Phase 4 trial update assessing empagliflozin for reducing progression of diabetic retinopathy in high-risk patients with diabetic macular ed…
-
CLINICAL_TRIALS trial_result · 2018-09-25Clinical Trial Update: Phase II Combination Steroid and Anti-VEGF for Persistent DME [Phase 2]
Phase II trial update on a combination therapy of steroids and anti-VEGF for persistent diabetic macular edema has completed with results po…
-
CLINICAL_TRIALS trial_result · 2018-09-14Clinical Trial Update: Efficacy & Safety Trial of Intravitreal Injections Combined With PRP for CSME Secondary to Diabetes Mellitus (DAVE) [Phase 1, Phase 2]
A combined intravitreal injection and PRP trial for diabetic macular edema completed phase 1/2 with posted results in 2018.
-
CLINICAL_TRIALS trial_result · 2018-09-14Clinical Trial Update: Multicenter Study to Evaluate the Efficacy of Treat and Extend Regimen of Aflibercept (EYLEA) as a Second Line Treatment for Diabetic Macular Edema [Phase 4]
Phase 4 multicenter trial evaluating aflibercept (EYLEA) treatment extended as a second-line regimen for diabetic macular edema has complete…
-
CLINICAL_TRIALS trial_result · 2018-09-07Clinical Trial Update: Combination Treatment of Intravitreal Ranibizumab, Focal/Grid Laser and Panretinal Photocoagulation in Patients With Diabetic Macula Edema [Phase 4]
Phase 4 trial update on combination therapy for diabetic macular edema using intravitreal ranibizumab with focal/grid laser and panretinal p…
-
CLINICAL_TRIALS withdrawal · 2018-08-22Clinical Trial Update: Retinal Ganglion Cell Function After Intravitreous Ranibizumab in Patients With Diabetic Macular Edema [Phase 4]
A Phase 4 clinical trial assessing retinal ganglion cell function after intravitreal ranibizumab in diabetic macular edema has been withdraw…
-
CLINICAL_TRIALS trial_result · 2018-08-20Clinical Trial Update: Combination OZURDEX® & LUCENTIS® vs. OZURDEX® Monotherapy in Incomplete-Responders With Diabetic Macular Edema [Phase 4]
Phase 4 trial assessing combination OZURDEX and LUCENTIS versus OZURDEX alone in incomplete responders with diabetic macular edema was termi…
-
FDA approval · 2018-08-16FDA Approved: EYLEA — Supplemental Application (Regeneron Pharmaceuticals, Inc.)
FDA has approved a supplemental application for EYLEA (aflibercept) from Regeneron Pharmaceuticals, Inc. The approval indicates the suppleme…
-
CLINICAL_TRIALS trial_result · 2018-07-30Clinical Trial Update: Assessment of EyeArt as an Automated Diabetic Retinopathy Screening Tool
This completed clinical trial assessed EyeArt, an automated screening tool for diabetic retinopathy, as a screening modality for diabetic ey…
-
CLINICAL_TRIALS trial_result · 2018-07-18Clinical Trial Update: Treatment of Diabetic Macular Edema (DME) With Anti-VEGF and Focal Laser [Phase 4]
Phase 4 trial evaluating the combination of anti-VEGF therapy with focal laser for diabetic macular edema has completed.
-
CLINICAL_TRIALS trial_result · 2018-07-18Clinical Trial Update: Rapid Structural and Functional Improvements in Following 0.19 mg Fluocinolone Acetonide (FAc) Implant in Diabetic Macular Edema Patients With Poor Visual Acuity: 12-month Audit Results From United Arab Emirates
A 12-month UAE audit reports rapid structural and functional improvements in diabetic macular edema patients with poor visual acuity treated…
-
CLINICAL_TRIALS trial_result · 2018-07-12Clinical Trial Update: Early Anatomical, Physiological, and Clinical Changes in Diabetic Macular Edema After Intravitreal Aflibercept Injection [Phase 4]
Phase 4 trial update on intravitreal aflibercept for diabetic macular edema and diabetic retinopathy reports early anatomical, physiological…
-
CLINICAL_TRIALS trial_result · 2018-07-11Clinical Trial Update: Multimodal Image Study of Retinal Inflammation Markers After Corticoid and Antiangiogenic Treatment in Pacients With Diabetic Macular Edema
This clinical trial update describes a multimodal imaging study of retinal inflammation markers following corticosteroid and antiangiogenic …
-
CLINICAL_TRIALS trial_result · 2018-06-27Clinical Trial Update: Comparison of Different Fluence Settings for Yellow Subthreshold Laser Treatment in Diabetic Macular Edema
Completed clinical trial comparing different fluence settings for yellow subthreshold laser treatment in diabetic macular edema.
-
CLINICAL_TRIALS withdrawal · 2018-06-14Clinical Trial Update: Intravitreal Alfibercept for Center Involved DME Previously Managed With Intravitreal Ranibizumab [Phase 4]
A phase 4 clinical trial evaluating intravitreal aflibercept for center-involved diabetic macular edema previously managed with ranibizumab …
-
CLINICAL_TRIALS trial_result · 2018-06-07Clinical Trial Update: Long-Term Efficacy & Safety of Aflibercept IVT for the Treatment of DME in Subjects Who Completed the VISTA-DME Trial [Phase 4]
Phase 4 trial update assessing long-term efficacy and safety of aflibercept IVT for diabetic macular edema after completion of VISTA-DME.
-
CLINICAL_TRIALS trial_result · 2018-05-21Clinical Trial Update: Retrospective Trial on the Efficacy and Safety of Intravitreal Ozurdex in Patients With Diabetic Macular Edema.
A retrospective study evaluated the efficacy and safety of the dexamethasone intravitreal implant (Ozurdex) in patients with diabetic macula…
-
CLINICAL_TRIALS trial_result · 2018-05-16Clinical Trial Update: Ozurdex for Diabetic Macular Edema Treated With Pars Plana vitrEctomy and Membrane RemovAl (OPERA Study) [Phase 4]
Phase 4 OPERA trial update evaluating Ozurdex for diabetic macular edema in patients undergoing pars plana vitrectomy with membrane removal;…
-
CLINICAL_TRIALS trial_result · 2018-05-09Clinical Trial Update: Study of DS-7080a for the Treatment of Macular Degeneration [Phase 1]
A Phase 1 clinical trial evaluating DS-7080a for neovascular age-related macular degeneration and diabetic macular edema has completed.